Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers-Reference-Cited by-同舟云学术

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers

Published:2016-08-18 Issue:7 Volume:115 Page:776-783
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Jonasson Jon G,Stefansson Olafur A,Johannsson Oskar T,Sigurdsson Helgi,Agnarsson Bjarni A,Olafsdottir Gudridur H,Alexiusdottir Kristin K,Stefansdottir Hrefna,Munoz Mitev Rodrigo,Olafsdottir Katrin,Olafsdottir Kristrun,Arason Adalgeir,Stefansdottir Vigdis,Olafsdottir Elinborg J,Barkardottir Rosa B,Eyfjord Jorunn E,Narod Steven A,Tryggvadóttir Laufey

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016249.pdf

Reference26 articles.

1. Arason A, Gunnarsson H, Johannesdottir G, Jonasson K, Bendahl PO, Gillanders EM, Agnarsson BA, Jönsson G, Pylkäs K, Mustonen A, Heikkinen T, Aittomäki K, Blomqvist C, Melin B, Johannsson OT, Møller P, Winqvist R, Nevanlinna H, Borg A, Barkardottir RB (2010) Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families. Breast Cancer Res 12 (4): R50.

2. Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, Mierzwa T, Szwiec M, Wisniowski R, Siolek M, Dent R, Lubinski J, Narod S (2010) Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol 28 (3): 375–379.

3. Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372 (9): 793–795.

4. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (16): 1233–1241.

5. Goodwin PJ, Phillips KA, West DW, Ennis M, Hopper JL, John EM, O’Malley FP, Milne RL, Andrulis IL, Friedlander ML, Southey MC, Apicella C, Giles GG, Longacre TA (2012) Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study. J Clin Oncol 30 (1): 19–26.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study;Cancer;2024-05-16

2. ER-positive and BRCA2-mutated breast cancer: a literature review;European Journal of Medical Research;2024-01-06

3. HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis;Therapeutic Advances in Medical Oncology;2024-01

4. Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients;npj Breast Cancer;2023-11-30

5. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants;npj Breast Cancer;2023-05-12